Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Emini

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Drug Design and Discovery|January 1, 1993
HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimeticsA K Ghosh, S P McKee, W M Sanders, et al.
Journal of Medicinal Chemistry|January 22, 1993
3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitorsA K Ghosh, W J Thompson, S P McKee, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitroM E Goldman, J A O'Brien, T L Ruffing, et al.
Journal of Medicinal Chemistry|April 30, 1993
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptaseT M Williams, T M Ciccarone, S C MacTough, et al.
Journal of Medicinal Chemistry|October 14, 1994
L-735,524: the design of a potent and orally bioavailable HIV protease inhibitorB D Dorsey, R B Levin, S L McDaniel, et al.
Journal of Medicinal Chemistry|May 15, 1992
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted designW J Thompson, P M Fitzgerald, M K Holloway, et al.
AIDS Research and Human Retroviruses|November 1, 1990
Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzeesE A Emini, W A Schleif, J C Quintero, et al.
Journal of Medicinal Chemistry|April 2, 1993
Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitorsA K Ghosh, W J Thompson, H Y Lee, et al.
Journal of Medicinal Chemistry|March 1, 1991
Benzocycloalkyl amines as novel C-termini for HIV protease inhibitorsT A Lyle, C M Wiscount, J P Guare, et al.
AIDS Research and Human Retroviruses|May 1, 1997
Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolatesJ A Kessler, P M McKenna, E A Emini, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Drug Design and Discovery|January 1, 1993
HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimeticsA K Ghosh, S P McKee, W M Sanders, et al.
Journal of Medicinal Chemistry|January 22, 1993
3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitorsA K Ghosh, W J Thompson, S P McKee, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitroM E Goldman, J A O'Brien, T L Ruffing, et al.
Journal of Medicinal Chemistry|April 30, 1993
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptaseT M Williams, T M Ciccarone, S C MacTough, et al.
Journal of Medicinal Chemistry|October 14, 1994
L-735,524: the design of a potent and orally bioavailable HIV protease inhibitorB D Dorsey, R B Levin, S L McDaniel, et al.
Journal of Medicinal Chemistry|May 15, 1992
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted designW J Thompson, P M Fitzgerald, M K Holloway, et al.
AIDS Research and Human Retroviruses|November 1, 1990
Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzeesE A Emini, W A Schleif, J C Quintero, et al.
Journal of Medicinal Chemistry|April 2, 1993
Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitorsA K Ghosh, W J Thompson, H Y Lee, et al.
Journal of Medicinal Chemistry|March 1, 1991
Benzocycloalkyl amines as novel C-termini for HIV protease inhibitorsT A Lyle, C M Wiscount, J P Guare, et al.
AIDS Research and Human Retroviruses|May 1, 1997
Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolatesJ A Kessler, P M McKenna, E A Emini, et al.
Pageof 10